Application 206418

Type
ANDA
Sponsor
WEST-WARD PHARMS INT

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
002TAPENTADOLTAPENTADOLTABLET, EXTENDED RELEASE;ORAL100MGNoNo
003TAPENTADOLTAPENTADOLTABLET, EXTENDED RELEASE;ORAL150MGNoNo
004TAPENTADOLTAPENTADOLTABLET, EXTENDED RELEASE;ORAL200MGNoNo
005TAPENTADOLTAPENTADOLTABLET, EXTENDED RELEASE;ORAL250MGNoNo